The pre filled syringes market size has grown rapidly in recent years. It will grow from $9.39 billion in 2025 to $10.77 billion in 2026 at a compound annual growth rate (CAGR) of 14.7%. The growth in the historic period can be attributed to growth in injectable drug therapies, expansion of chronic disease treatment protocols, increasing use of biologics and biosimilars, rising demand for safe drug delivery systems, improvements in pharmaceutical packaging standards.
The pre filled syringes market size is expected to see rapid growth in the next few years. It will grow to $18.29 billion in 2030 at a compound annual growth rate (CAGR) of 14.2%. The growth in the forecast period can be attributed to increasing adoption of self-administration drug formats, rising investments in advanced drug delivery technologies, expansion of biologics pipeline products, growing focus on patient-centric packaging, increasing regulatory emphasis on injection safety. Major trends in the forecast period include increasing adoption of safety-engineered prefilled syringes, rising demand for ready-to-use injectable formats, growing use of plastic and polymer-based syringes, expansion of customized and dual-chamber designs, enhanced focus on dose accuracy and sterility.
The growing adoption of home-based healthcare is expected to support the expansion of the pre-filled syringe market during the forecast period. Home-based healthcare involves the provision of medical treatment and supportive services to patients within their homes, enabling recovery, chronic disease management, and ongoing care in a familiar and convenient environment. Pre-filled syringes are well aligned with this shift in care delivery, as they offer accurate dosing, lower contamination risk, and enhanced ease of use, which together improve patient adherence and overall quality of care in home settings. For example, in February 2023, according to the National Association for Home Care and Hospice, a United States-based non-profit organization representing individuals requiring long-term and end-of-life care, nearly 12 million Americans receive some form of home healthcare annually, with this number expected to increase further. Therefore, the rising preference for home-based healthcare is anticipated to drive market growth over the forecast period.
Leading healthcare companies in the pre-filled syringe market are seeking approval for innovative products, such as single-dose pre-filled syringes, to broaden their presence in the healthcare sector. Single-dose pre-filled syringes, which contain a disposable syringe preloaded with medication liquid for injection, offer a convenient solution for administering treatments. For example, in March 2023, the Food and Drug Administration (FDA) granted approval for Emerphed (ephedrine sulfate injection) in 25 mg/5 mL and 50 mg/10 mL single-dose pre-filled syringes manufactured by Nexus Pharmaceuticals Inc., a US-based pharmaceutical company. This marks the FDA's approval of the first 10-milliliter (mL) pre-filled syringe for ephedrine sulfate injection.
In September 2023, Sharps Technology Inc., a United States-based medical device company, completed the acquisition of Nephron Pharmaceuticals Corporation’s InjectEZ specialty copolymer syringe manufacturing facility for approximately USD 50 million. Through this transaction, Sharps sought to establish and expand its presence in the rapidly growing copolymer prefillable syringe segment, secure long-term production volumes supported by a 10-year purchase commitment from Nephron, enhance its domestic manufacturing capabilities, and accelerate the commercialization of its next-generation prefilled syringe platforms. Nephron Pharmaceuticals Corporation is a United States-based contract manufacturing organization focused on sterile injectable pharmaceuticals, prefilled syringe solutions, and contract manufacturing services for hospital and healthcare applications.
Major companies operating in the pre filled syringes market are Becton Dickinson and Company, Gerresheimer AG, Schott & Associates Glass Technology Laboratory, West Pharmaceutical Services Inc., Baxter International, Nipro Corporation, Terumo Corporation, Vetter Pharma International GmbH, Stevanato Group SPA, Shandong Weigao Group Medical Polymer Company Ltd., Novartis AG, Catalent Inc., Unilife Corporation, Eli Lilly and Company, Bayer AG, Pfizer Inc., Bristol-Myers Squibb Co., F. Hoffman-La Roche Ltd., AbbVie Inc., Owen Mumford Holdings Ltd., AptarGroup Inc., Medtronic Plc, Abbott Laboratories, Fresenius Kabi India Pvt. Ltd., Medical Protective Ltd., Mylan NV, Elcam Medical Inc., YPSOMED Holding AG, Oval Medical Technologies, SHL Medical, ACASI Machinery Inc., Bespak Holdings Ltd., BioPharma Solutions, Catalent Pharma Solutions, Credence MedSystems Inc., Hasemeier Inc., Intas Pharmaceuticals Ltd., Intelicure Lifesciences, Mycoscience Labs.
Europe was the largest region in the prefilled syringes market in 2025. The regions covered in the pre filled syringes market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pre filled syringes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the pre-filled syringes market by raising costs of imported glass tubing, medical-grade plastics, elastomers, and precision manufacturing equipment used in syringe production. Pharmaceutical manufacturing hubs in Europe and North America are most affected due to reliance on cross-border raw material sourcing, while Asia-Pacific faces export cost pressures. These tariffs are increasing production costs and affecting pricing strategies for injectable drugs. At the same time, they are driving localization of syringe manufacturing, supplier diversification, and innovation in alternative materials to reduce import dependency.
The pre filled syringes market research report is one of a series of new reports that provides pre filled syringes market statistics, including pre filled syringes industry global market size, regional shares, competitors with a pre filled syringes market share, detailed pre filled syringes market segments, market trends and opportunities, and any further data you may need to thrive in the pre filled syringes industry. This pre filled syringes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Pre-filled syringes refer to syringes that come pre-loaded with the substance intended for injection, facilitating the accurate delivery of the contents to the desired location.
The primary types of pre-filled syringes include conventional pre-filled syringes and safety pre-filled syringes. Conventional pre-filled syringes typically contain a single-dose packet of vaccines, with a manufacturer-fixed needle designed for one-time use. After application, the syringe is disposed of. Safety pre-filled syringes, on the other hand, contain a single-dose packet of vaccine intended for self-administration by patients who require regular injections in a home setting. Needles for these syringes are crafted from materials such as glass and plastic, and the syringes come in various forms, including single-chamber pre-filled syringes, dual-chamber pre-filled syringes, and customized pre-filled syringes. These pre-filled syringes find applications in a range of medical conditions such as diabetes, rheumatoid arthritis, anaphylaxis, cancer, thrombosis, ophthalmology, and others.
The pre-filled syringes market consists of sales of glass prefilled syringes and plastic prefilled syringes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The pre filled syringes market size is expected to see rapid growth in the next few years. It will grow to $18.29 billion in 2030 at a compound annual growth rate (CAGR) of 14.2%. The growth in the forecast period can be attributed to increasing adoption of self-administration drug formats, rising investments in advanced drug delivery technologies, expansion of biologics pipeline products, growing focus on patient-centric packaging, increasing regulatory emphasis on injection safety. Major trends in the forecast period include increasing adoption of safety-engineered prefilled syringes, rising demand for ready-to-use injectable formats, growing use of plastic and polymer-based syringes, expansion of customized and dual-chamber designs, enhanced focus on dose accuracy and sterility.
The growing adoption of home-based healthcare is expected to support the expansion of the pre-filled syringe market during the forecast period. Home-based healthcare involves the provision of medical treatment and supportive services to patients within their homes, enabling recovery, chronic disease management, and ongoing care in a familiar and convenient environment. Pre-filled syringes are well aligned with this shift in care delivery, as they offer accurate dosing, lower contamination risk, and enhanced ease of use, which together improve patient adherence and overall quality of care in home settings. For example, in February 2023, according to the National Association for Home Care and Hospice, a United States-based non-profit organization representing individuals requiring long-term and end-of-life care, nearly 12 million Americans receive some form of home healthcare annually, with this number expected to increase further. Therefore, the rising preference for home-based healthcare is anticipated to drive market growth over the forecast period.
Leading healthcare companies in the pre-filled syringe market are seeking approval for innovative products, such as single-dose pre-filled syringes, to broaden their presence in the healthcare sector. Single-dose pre-filled syringes, which contain a disposable syringe preloaded with medication liquid for injection, offer a convenient solution for administering treatments. For example, in March 2023, the Food and Drug Administration (FDA) granted approval for Emerphed (ephedrine sulfate injection) in 25 mg/5 mL and 50 mg/10 mL single-dose pre-filled syringes manufactured by Nexus Pharmaceuticals Inc., a US-based pharmaceutical company. This marks the FDA's approval of the first 10-milliliter (mL) pre-filled syringe for ephedrine sulfate injection.
In September 2023, Sharps Technology Inc., a United States-based medical device company, completed the acquisition of Nephron Pharmaceuticals Corporation’s InjectEZ specialty copolymer syringe manufacturing facility for approximately USD 50 million. Through this transaction, Sharps sought to establish and expand its presence in the rapidly growing copolymer prefillable syringe segment, secure long-term production volumes supported by a 10-year purchase commitment from Nephron, enhance its domestic manufacturing capabilities, and accelerate the commercialization of its next-generation prefilled syringe platforms. Nephron Pharmaceuticals Corporation is a United States-based contract manufacturing organization focused on sterile injectable pharmaceuticals, prefilled syringe solutions, and contract manufacturing services for hospital and healthcare applications.
Major companies operating in the pre filled syringes market are Becton Dickinson and Company, Gerresheimer AG, Schott & Associates Glass Technology Laboratory, West Pharmaceutical Services Inc., Baxter International, Nipro Corporation, Terumo Corporation, Vetter Pharma International GmbH, Stevanato Group SPA, Shandong Weigao Group Medical Polymer Company Ltd., Novartis AG, Catalent Inc., Unilife Corporation, Eli Lilly and Company, Bayer AG, Pfizer Inc., Bristol-Myers Squibb Co., F. Hoffman-La Roche Ltd., AbbVie Inc., Owen Mumford Holdings Ltd., AptarGroup Inc., Medtronic Plc, Abbott Laboratories, Fresenius Kabi India Pvt. Ltd., Medical Protective Ltd., Mylan NV, Elcam Medical Inc., YPSOMED Holding AG, Oval Medical Technologies, SHL Medical, ACASI Machinery Inc., Bespak Holdings Ltd., BioPharma Solutions, Catalent Pharma Solutions, Credence MedSystems Inc., Hasemeier Inc., Intas Pharmaceuticals Ltd., Intelicure Lifesciences, Mycoscience Labs.
Europe was the largest region in the prefilled syringes market in 2025. The regions covered in the pre filled syringes market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pre filled syringes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the pre-filled syringes market by raising costs of imported glass tubing, medical-grade plastics, elastomers, and precision manufacturing equipment used in syringe production. Pharmaceutical manufacturing hubs in Europe and North America are most affected due to reliance on cross-border raw material sourcing, while Asia-Pacific faces export cost pressures. These tariffs are increasing production costs and affecting pricing strategies for injectable drugs. At the same time, they are driving localization of syringe manufacturing, supplier diversification, and innovation in alternative materials to reduce import dependency.
The pre filled syringes market research report is one of a series of new reports that provides pre filled syringes market statistics, including pre filled syringes industry global market size, regional shares, competitors with a pre filled syringes market share, detailed pre filled syringes market segments, market trends and opportunities, and any further data you may need to thrive in the pre filled syringes industry. This pre filled syringes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Pre-filled syringes refer to syringes that come pre-loaded with the substance intended for injection, facilitating the accurate delivery of the contents to the desired location.
The primary types of pre-filled syringes include conventional pre-filled syringes and safety pre-filled syringes. Conventional pre-filled syringes typically contain a single-dose packet of vaccines, with a manufacturer-fixed needle designed for one-time use. After application, the syringe is disposed of. Safety pre-filled syringes, on the other hand, contain a single-dose packet of vaccine intended for self-administration by patients who require regular injections in a home setting. Needles for these syringes are crafted from materials such as glass and plastic, and the syringes come in various forms, including single-chamber pre-filled syringes, dual-chamber pre-filled syringes, and customized pre-filled syringes. These pre-filled syringes find applications in a range of medical conditions such as diabetes, rheumatoid arthritis, anaphylaxis, cancer, thrombosis, ophthalmology, and others.
The pre-filled syringes market consists of sales of glass prefilled syringes and plastic prefilled syringes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Pre Filled Syringes Market Characteristics
3. Pre Filled Syringes Market Supply Chain Analysis
4. Global Pre Filled Syringes Market Trends and Strategies
5. Pre Filled Syringes Market Analysis of End Use Industries
7. Global Pre Filled Syringes Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Pre Filled Syringes Total Addressable Market (TAM) Analysis for the Market
9. Pre Filled Syringes Market Segmentation
10. Pre Filled Syringes Market Regional and Country Analysis
11. Asia-Pacific Pre Filled Syringes Market
12. China Pre Filled Syringes Market
13. India Pre Filled Syringes Market
14. Japan Pre Filled Syringes Market
15. Australia Pre Filled Syringes Market
16. Indonesia Pre Filled Syringes Market
17. South Korea Pre Filled Syringes Market
18. Taiwan Pre Filled Syringes Market
19. South East Asia Pre Filled Syringes Market
20. Western Europe Pre Filled Syringes Market
21. UK Pre Filled Syringes Market
22. Germany Pre Filled Syringes Market
23. France Pre Filled Syringes Market
24. Italy Pre Filled Syringes Market
25. Spain Pre Filled Syringes Market
26. Eastern Europe Pre Filled Syringes Market
27. Russia Pre Filled Syringes Market
28. North America Pre Filled Syringes Market
29. USA Pre Filled Syringes Market
30. Canada Pre Filled Syringes Market
31. South America Pre Filled Syringes Market
32. Brazil Pre Filled Syringes Market
33. Middle East Pre Filled Syringes Market
34. Africa Pre Filled Syringes Market
36. Pre Filled Syringes Market Competitive Landscape and Company Profiles
37. Pre Filled Syringes Market Other Major and Innovative Companies
40. Pre Filled Syringes Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Pre Filled Syringes Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses pre filled syringes market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for pre filled syringes? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pre filled syringes market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Conventional Prefilled Syringes; Safety Prefilled Syringes2) By Material: Glass Prefilled Syringes; Plastic Prefilled Syringes
3) By Design: Single-Chamber Prefilled Syringes; Dual- Chamber Prefilled Syringes; Customized Prefilled Syringes
4) By Application: Diabetes; Rheumatoid Arthritis; Anaphylaxis; Cancer; Thrombosis; Ophthalmology; Other Applications
Subsegments:
1) By Conventional Prefilled Syringes: Glass Prefilled Syringes; Plastic Prefilled Syringes2) By Safety Prefilled Syringes: Retractable Needle Syringes; Non-Retractable Needle Syringes
Companies Mentioned: Becton Dickinson and Company; Gerresheimer AG; Schott & Associates Glass Technology Laboratory; West Pharmaceutical Services Inc.; Baxter International; Nipro Corporation; Terumo Corporation; Vetter Pharma International GmbH; Stevanato Group SPA; Shandong Weigao Group Medical Polymer Company Ltd.; Novartis AG; Catalent Inc.; Unilife Corporation; Eli Lilly and Company; Bayer AG; Pfizer Inc.; Bristol-Myers Squibb Co.; F. Hoffman-La Roche Ltd.; AbbVie Inc.; Owen Mumford Holdings Ltd.; AptarGroup Inc.; Medtronic Plc; Abbott Laboratories; Fresenius Kabi India Pvt. Ltd.; Medical Protective Ltd.; Mylan NV; Elcam Medical Inc.; YPSOMED Holding AG; Oval Medical Technologies; SHL Medical; ACASI Machinery Inc.; Bespak Holdings Ltd.; BioPharma Solutions; Catalent Pharma Solutions; Credence MedSystems Inc.; Hasemeier Inc.; Intas Pharmaceuticals Ltd.; Intelicure Lifesciences; Mycoscience Labs
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Pre Filled Syringes market report include:- Becton Dickinson and Company
- Gerresheimer AG
- Schott & Associates Glass Technology Laboratory
- West Pharmaceutical Services Inc.
- Baxter International
- Nipro Corporation
- Terumo Corporation
- Vetter Pharma International GmbH
- Stevanato Group SPA
- Shandong Weigao Group Medical Polymer Company Ltd.
- Novartis AG
- Catalent Inc.
- Unilife Corporation
- Eli Lilly and Company
- Bayer AG
- Pfizer Inc.
- Bristol-Myers Squibb Co.
- F. Hoffman-La Roche Ltd.
- AbbVie Inc.
- Owen Mumford Holdings Ltd.
- AptarGroup Inc.
- Medtronic Plc
- Abbott Laboratories
- Fresenius Kabi India Pvt. Ltd.
- Medical Protective Ltd.
- Mylan NV
- Elcam Medical Inc.
- YPSOMED Holding AG
- Oval Medical Technologies
- SHL Medical
- ACASI Machinery Inc.
- Bespak Holdings Ltd.
- BioPharma Solutions
- Catalent Pharma Solutions
- Credence MedSystems Inc.
- Hasemeier Inc.
- Intas Pharmaceuticals Ltd.
- Intelicure Lifesciences
- Mycoscience Labs
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 10.77 Billion |
| Forecasted Market Value ( USD | $ 18.29 Billion |
| Compound Annual Growth Rate | 14.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 40 |
